Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
NCT06196034

Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.

Led by Chinese University of Hong Kong · Updated on 2026-03-18

2000

Participants Needed

2

Research Sites

252 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

There is limited information on genetics associated with asthma in Chinese. An earlier meta-analysis found that ADAM33, FcεRIb, RANTES, TNF-a, ACE, b2-AR, IL-4R and IL-13 genes could be proposed as asthma susceptible genes in the Chinese population. However, given the limited number of studies, more data are required to validate these associations. Future research must address key issues such as the broad clinical variability of asthma and the underrepresentation of populations of non-European heritage. Endotype-specific SNPs and unique biological insights may be obtained by conducting GWAS/EWAS on homogeneous populations of more therapy-resistant T2-low, adult-onset, obesity-associated asthma or asthma with particular co-morbidities. The primary objective is to investigate the association between genetic polymorphisms and various severities of asthma.

CONDITIONS

Official Title

Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.

Who Can Participate

Age: 18Years - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • All patients with confirmed diagnosis of asthma, demonstrated by consistent history and prior tests showing variable airflow obstruction with increase in FEV1 greater than 12% or 400 mL after bronchodilator, or bronchial hyperresponsiveness when stable
  • Able to provide written informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Patients currently with acute asthma exacerbation; can join study after 6 weeks post recovery
  • Patients with respiratory diseases mimicking chronic airway diseases such as bronchiectasis, tuberculosis-damaged lung, endobronchial tuberculosis, or lung cancer, or with history of these conditions
  • Patients currently diagnosed with pneumonia or acute bronchitis
  • Control subjects must have no clinical diagnosis of asthma

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

The Chinese University of Hong Kong

Hong Kong, New Territories, Hong Kong

Actively Recruiting

2

The Chinese University of Hong Kong

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

D

David SC Hui, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here